Sales and Marketing

Showing 15 posts of 11527 posts found.

EMA speeds up Boehringer review

November 28, 2013 Sales and Marketing Boehringer, faldaprevir, hepc

Boehringer Ingelheim’s hepatitis C candidate faldaprevir has moved a potential step closer to market with the news that the European …

NICE rejects Bosulif

November 28, 2013 Sales and Marketing CML, NHS, NICE, Pfizer, bosulif

 In a blow for Pfizer NICE has categorically rejected the manufacturer’s Bosulif as a treatment for previously-treated chronic myeloid leukaemia …

Francis report author becomes Patients Association president

November 28, 2013 Sales and Marketing Mid Staffs, NHS, robert francis, scandal

The author of a damning report into failings at the Staffordshire hospital has become the new president of the Patients …

PiR Resourcing hires client services director

November 28, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing perry evans, pir resourcing

Life science talent management firm PiR Resourcing has appointed industry veteran Perry Evans to be its Client Services director.  PiR …

Third failure for Sanofi/Merrimack cancer drug

November 27, 2013 Research and Development, Sales and Marketing Cancer, Sanofi, merrimack, mm-121

Sanofi and partner Merrimack have posted yet more disappointing results for their investigational cancer medicine MM-121. In the latest study …

NICE gives Lucentis more scope

November 27, 2013 Sales and Marketing Lucentis, NICE, Novartis, cnv

An undisclosed price cut from Novartis has been enough to swing NICE towards using the manufacturer’s Lucentis in a fourth …

Bayer targets Norway’s Algeta

November 27, 2013 Sales and Marketing Algeta, Bayer, oncology, xofigo

Bayer HealthCare is in the market to buy Norwegian oncology specialist Algeta. The German pharma group has made a bid …

Aesica appoints new site manufacturing manager

November 27, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Aesica, catherine dick

Contract development and manufacturing organisation Aesica has appointed Catherine Dick to the role of site manufacturing manager. She will take …

Gilead runs into India patent trouble

November 26, 2013 Sales and Marketing Gilead, MSF, hepc, sofosbuvir, sovaldi

Gilead Sciences has run into heavy traffic in India as campaigners attempt to block the company’s patent there on new …

Google diagnostic firm receives scathing FDA warning

November 26, 2013 Medical Communications, Research and Development, Sales and Marketing FDA, dna. 23andme, google

The Google-backed DNA testing firm 23andMe has received a warning letter from the FDA saying it cannot continue to market …

FDA U-turn on Avandia

November 26, 2013 Sales and Marketing Avandia, CDER, FDA, GSK, diabetes, nissen, type 2

The FDA has delivered a shock verdict that the stringent restrictions on GlaxoSmithKline’s diabetes medicine Avandia should be lifted, despite …

3-V Biosciences hires chief medical officer

November 26, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 3V, biosciences, mcculloch

Clinical-stage biopharma firm 3-V Biosciences has taken on Dr William McCulloch as its chief medical officer.  McCulloch brings nearly three …

PPRS deal ‘dreadful’, says EMIG

November 26, 2013 Sales and Marketing EMIG, NHS, NICE, PPRS, VBP

The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …

US regulator shows Nexavar green light

November 25, 2013 Sales and Marketing Bayer, Cancer, FDA, Nexavar, Onyx, thyroid

The FDA has extended the indication of liver and kidney cancer pill Nexavar to treat late-stage differentiated thyroid cancer. It …
The Gateway to Local Adoption Series

Latest content